BDUUF
Company Description
Bangkok Dusit Medical Services Public Company Limited, together with its subsidiaries, operates hospitals. The company owns and manages 6 hospital groups, including Bangkok Hospital Group, Samitivej Hospital Group, BNH Hospital, Phyathai Hospital Group, Paolo Hospital Group, and Royal Hospital Group. It operates holistic clinical wellness. In addition, the company operates hotels and restaurant; sells health and cosmetic products; provides accounting, health insurance, laboratory services, investment, information technology, training, skin and aesthetics telemedicine, genome sequencing, insurance brokerage, air medical transportation, facility management, and property management services, as well as asset management services; and manufactures and distributes medicine and pharmaceutical products. Further, it is involved in the e-commerce and real estate business. The company operates 47 hospitals in Thailand and Cambodia. Bangkok Dusit Medical Services Public Company Limited was incorporated in 1969 and is based in Bangkok, Thailand.
Track Record
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 111.42B | 107.87B | 100.85B | 91.93B | 74.45B | 68.07B | 82.72B | 78.42B | 71.93B | 67.99B | 62.86B | 56.05B |
| Net Income | 15.84B | 15.99B | 14.38B | 12.61B | 7.94B | 7.21B | 15.52B | 9.19B | 10.22B | 8.39B | 8.02B | 7.39B |
| EPS | 1.00 | 1.01 | 0.90 | 0.79 | 0.50 | 0.45 | 0.99 | 0.59 | 0.66 | 0.54 | 0.52 | 0.48 |
| Free Cash Flow | 13.02B | 11.28B | 12.47B | 15.19B | 10.19B | 5.03B | 6.55B | 7.11B | (4.67B) | 3.47B | N/A | N/A |
| FCF / Share | 0.82 | 0.71 | 0.78 | 0.96 | 0.64 | 0.32 | 0.42 | 0.46 | -0.30 | 0.22 | N/A | N/A |
| Operating CF | 23.43B | 22.96B | 20.78B | 20.27B | 14.56B | 11.68B | 14.55B | 14.80B | 10.93B | 12.45B | N/A | N/A |
| Total Assets | 157.83B | 151.51B | 143.60B | 141.54B | 128.45B | 136.05B | 133.66B | 133.50B | 122.63B | 106.94B | N/A | N/A |
| Total Debt | 17.49B | 18.36B | 18.13B | 23.59B | 18.83B | 24.25B | 24.43B | 39.95B | 39.34B | 31.90B | N/A | N/A |
| Cash & Equiv | 6.34B | 7.37B | 7.79B | 12.67B | 10.93B | 19.67B | 4.70B | 5.03B | 5.09B | 4.22B | N/A | N/A |
| Book Value | 105.81B | 100.04B | 95.44B | 89.88B | 83.85B | 87.91B | 83.81B | 70.32B | 63.07B | 55.72B | N/A | N/A |
| Return on Equity | 0.15 | 0.16 | 0.15 | 0.14 | 0.09 | 0.08 | 0.19 | 0.13 | 0.16 | 0.15 | N/A | N/A |
| Metric | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 28.21B | 28.43B | 28.24B | 26.73B | 28.08B | 27.40B | 28.15B | 25.70B | 26.61B | 26.34B | 26.42B | 24.08B |
| Net Income | 4.06B | 3.69B | 4.32B | 3.49B | 4.35B | 4.33B | 4.25B | 3.33B | 4.07B | 3.95B | 3.89B | 3.05B |
| EPS | 0.25 | 0.23 | 0.27 | 0.22 | 0.27 | 0.27 | 0.27 | 0.21 | 0.26 | 0.25 | 0.24 | 0.19 |
| Free Cash Flow | 4.82B | 2.01B | 112.39M | 2.55B | 4.40B | 560.83M | 3.28B | 2.34B | 5.15B | 1.70B | 2.81B | 3.53B |
| FCF / Share | 0.30 | 0.13 | 0.01 | 0.16 | 0.28 | 0.04 | 0.21 | 0.15 | 0.32 | 0.11 | 0.18 | 0.22 |
| Operating CF | 6.57B | 4.25B | 193.75M | 5.07B | 7.77B | 4.32B | 6.18B | 4.95B | 7.57B | 3.95B | 5.35B | 5.48B |
| Total Assets | 160.85B | 157.83B | 152.89B | 151.57B | 154.21B | 151.51B | 148.35B | 144.72B | 147.95B | 143.60B | 139.89B | 138.66B |
| Total Debt | 14.04B | 25.07B | 18.66B | 16.42B | 15.89B | 18.36B | 19.69B | 15.69B | 16.69B | 18.13B | 19.88B | 18.18B |
| Cash & Equiv | 7.38B | 6.34B | 5.70B | 5.32B | 9.06B | 7.37B | 9.03B | 7.14B | 11.34B | 7.79B | 8.22B | 10.44B |
| Book Value | 110.30B | 105.81B | 100.21B | 101.55B | 104.59B | 100.04B | 95.99B | 97.52B | 99.71B | 95.24B | 90.10B | 91.78B |
| Return on Equity | 0.04 | 0.03 | 0.04 | 0.03 | 0.04 | 0.04 | 0.04 | 0.03 | 0.04 | 0.04 | 0.04 | 0.03 |